| Literature DB >> 32879802 |
Zhongwu Su1,2, Hao Xiong1,2, Yi Liu3, Jiaqi Pang1,2, Hanqing Lin1,2, Weijian Zhang1,2, Yiqing Zheng1,2.
Abstract
BACKGROUND: In our aging society, age-related hearing loss (AHL) is the most common sensory disorder in old people. Much progress has been made in understanding the pathological process of AHL over the past few decades. However, the mechanism of cochlear degeneration during aging is still not fully understood.Entities:
Keywords: Age-related hearing loss; Aging; Apoptosis; Inflammation; Necroptosis; RNA sequencing
Year: 2020 PMID: 32879802 PMCID: PMC7443093 DOI: 10.7717/peerj.9737
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1Differentially expressed mRNAs in the cochlea of aged C57BL/6 mice.
(A) Volcano plot showing comparative mRNA expression in the cochlea of the young and old C57BL/6 mice (n = 3). Red dots represent the significantly upregulated transcripts (379) and green dots indicate the significantly downregulated transcripts (352) in old mice (p-adjust < 0.05). Blue dots: no significant difference. (B) Heat map showing hierarchical clustering of differentially expressed mRNAs. Red indicates upregulation and blue representes downregulation. (C–G) Validation of five differentially expressed mRNAs by real-time qPCR. Bars show mean ± SD. *p < 0.05, **p < 0.01.
Top 20 upregulated DEGs in the aged cochlea compared to the young cochlea.
| No. | Gene | Description | log 2 fold change |
|---|---|---|---|
| 1 | Cd300ld3 | CD300 molecule like family member D3 | Infinity |
| 2 | Cxcl13 | Chemokine (C–X–C motif) ligand 13 | 4.838 |
| 3 | F830016B08Rik | RIKEN cDNA F830016B08 gene | 4.735 |
| 4 | Ms4a4c | Membrane-spanning 4-domains, subfamily A, member 4C | 4.489 |
| 5 | Muc5b | Mucin 5, subtype B, tracheobronchial | 4.401 |
| 6 | Mx1 | MX dynamin-like GTPase 1 | 4.248 |
| 7 | Zbp1 | Z-DNA binding protein 1 | 4.037 |
| 8 | Itgax | Integrin alpha X | 3.867 |
| 9 | Irf7 | Interferon regulatory factor 7 | 3.705 |
| 10 | Serpina3n | Serine (or cysteine) peptidase inhibitor, clade A, member 3N | 3.636 |
| 11 | Ccl2 | Chemokine (C–C motif) ligand 2 | 3.595 |
| 12 | Gbp10 | Guanylate-binding protein 10 | 3.467 |
| 13 | Tgtp1 | T cell specific GTPase 1 | 3.377 |
| 14 | Siglec1 | Sialic acid binding Ig-like lectin 1 | 3.364 |
| 15 | H2-Q6 | Histocompatibility 2, Q region locus 6 | 3.328 |
| 16 | Gm4951 | Predicted gene 4951 | 3.322 |
| 17 | Ifi44 | Interferon-induced protein 44 | 3.303 |
| 18 | Oas1g | 2′–5′ Oligoadenylate synthetase 1G | 3.073 |
| 19 | Gm4841 | Predicted gene 4841 | 3.045 |
| 20 | Alox15 | Arachidonate 15-lipoxygenase | 3.034 |
Top 20 downregulated DEGs in the aged cochlea compared to the young cochlea.
| No. | Gene | Description | log 2 fold change |
|---|---|---|---|
| 1 | Bglap | Bone gamma carboxyglutamate protein | −3.618 |
| 2 | St6galnac6 | ST6 | −3.557 |
| 3 | Col1a1 | Collagen, type I, alpha 1 | −3.505 |
| 4 | Slc4a1 | Solute carrier family 4 member 1 | −3.157 |
| 5 | Ppp1r26 | Protein phosphatase 1, regulatory subunit 26 | −2.879 |
| 6 | Ibsp | Integrin binding sialoprotein | −2.858 |
| 7 | Gypa | Glycophorin A | −2.703 |
| 8 | Col3a1 | Collagen, type III, alpha 1 | −2.427 |
| 9 | Gpr165 | G protein-coupled receptor 165 | −2.390 |
| 10 | Myl1 | Myosin, light polypeptide 1 | −2.372 |
| 11 | Bpifa1 | BPI fold containing family A, member 1 | −2.338 |
| 12 | Nrg1 | Neuregulin 1 | −2.316 |
| 13 | Bves | Blood vessel epicardial substance | −2.281 |
| 14 | Mmp8 | Matrix metallopeptidase 8 | −2.034 |
| 15 | Mepe | Matrix extracellular phosphoglycoprotein | −2.007 |
| 16 | Galnt13 | Polypeptide | −2.002 |
| 17 | Col1a2 | Collagen, type I, alpha 2 | −1.965 |
| 18 | Hapln1 | Hyaluronan and proteoglycan link protein 1 | −1.963 |
| 19 | Kif21a | Kinesin family member 21A | −1.961 |
| 20 | S100a8 | S100 calcium binding protein A8 | −1.942 |
Genes related to aging.
| No. | Gene | Description | log 2 fold change |
|---|---|---|---|
| 1 | Il7r | Interleukin 7 receptor | 2.607 |
| 2 | Fos | FBJ osteosarcoma oncogene | 1.955 |
| 3 | C1qa | Complement component 1, q subcomponent, alpha polypeptide | 1.893 |
| 4 | Egr1 | Early growth response 1 | 1.419 |
| 5 | Ccn2 | Cellular communication network factor 2 | 1.158 |
| 6 | Sncg | Synuclein gamma | 1.009 |
| 7 | Uchl1 | Ubiquitin carboxy-terminal hydrolase L1 | −1.126 |
| 8 | Kl | Klotho | −1.182 |
| 9 | Arntl | Aryl hydrocarbon receptor nuclear translocator like | −1.220 |
| 10 | Nrg1 | Neuregulin 1 | −2.316 |
Genes related to apoptosis and necroptosis.
| No. | Gene | Description | log 2 fold change |
|---|---|---|---|
| 1 | Fos | FBJ osteosarcoma oncogene | 1.955 |
| 2 | Casp4 | Caspase 4 | 1.862 |
| 3 | Gadd45g | Growth arrest and DNA damage inducible gamma | 1.838 |
| 4 | Xaf1 | XIAP associated factor 1 | 1.758 |
| 5 | Nr4a1 | Nuclear receptor subfamily 4 group a member 1 | 1.567 |
| 6 | Ddit4 | DNA damage inducible transcript 4 | 1.569 |
| 7 | Gdf15 | Growth differentiation factor 15 | 1.520 |
| 8 | Tnfrsf12a | TNF receptor superfamily member 12a | 1.435 |
| 9 | Egr1 | Early growth response 1 | 1.419 |
| 10 | Slc5a11 | Solute carrier family 5 member 11 | 1.406 |
| 11 | Parp3 | Poly(ADP-ribose) polymerase family member 3 | 1.160 |
| 12 | Anxa1 | Annexin a1 | 1.137 |
| 13 | Hk2 | Hexokinase 2 | 1.082 |
| 14 | Gadd45b | Growth arrest and DNA damage inducible beta | 1.050 |
| 15 | Ctsc | Cathepsin c | 1.042 |
| 16 | Mlkl | Mixed lineage kinase domain like pseudokinase | 1.031 |
Markers specific and/or consistent with the presence of macrophages/dendritic cells.
| No. | Gene | Description | log 2 fold change |
|---|---|---|---|
| 1 | Ptprc | Protein tyrosine phosphatase, receptor type, C | 1.408 |
| 2 | Cd68 | CD68 antigen | 1.822 |
| 3 | Cd14 | CD14 antigen | 1.799 |
| 4 | H2-Aa | Histocompatibility 2, class II antigen A, alpha | 2.822 |
| 5 | H2-Ab1 | Histocompatibility 2, class II antigen A, beta 1 | 2.977 |
| 6 | H2-Eb1 | Histocompatibility 2, class II antigen E beta | 2.718 |
| 7 | Lgals3 | Lectin, galactose binding, soluble 3 | 2.526 |
| 8 | Itgax | Integrin alpha X | 3.867 |
| 9 | H2-K1 | Histocompatibility 2, K1, K region | 1.589 |
| 10 | C1ra | Complement component 1, r subcomponent A | 1.184 |
| 11 | C1qa | Complement component 1, q subcomponent, alpha polypeptide | 1.893 |
| 12 | C1qb | Complement component 1, q subcomponent, beta polypeptide | 1.743 |
| 13 | C3 | Complement component 3 | 2.157 |
| 14 | C4b | Complement component 4 | 2.237 |
| 15 | Ctss | Cathepsin S | 2.115 |
| 16 | Mpeg1 | Macrophage expressed gene 1 | 2.048 |
| 17 | Fcgr1 | Fc receptor, IgG, high affinity I | 1.975 |
| 18 | Fcgr2b | Fc receptor, IgG, low affinity IIb | 1.107 |
Figure 2GO and KEGG analysis of the total differentially expressed genes.
(A) GO enrichment analysis of the total DEGs. p-adjust < 0.05. (B) KEGG enrichment analysis of the total DEGs. p-adjust < 0.05.
Figure 3GO and KEGG analysis of the upregulated DEGs.
(A) GO enrichment analysis of the upregulated DEGs. p-adjust < 0.05. (B) KEGG enrichment analysis of the upregulated DEGs. p-adjust < 0.05.
Figure 4GO and KEGG analysis of the downregulated DEGs.
(A) GO enrichment analysis of the downregulated DEGs. p-adjust < 0.05. (B) KEGG enrichment analysis of the downregulated DEGs. p < 0.05.
Figure 5H2O2 induced inflammation and necroptosis in HEI-OC1 cells.
HEI-OC1 cells were treated with 500 μM H2O2 for 6 h. (A–F) Real-time qPCR analysis showed that H2O2 treatment increased the expression of CCL2, IRF7, ZBP1, CEBPB, FOS and MLKL. Bars show mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001.